Filter by: patients
Home > Community Treatment Reports and Side Effects > Rotigotine Treatment Report
What is Rotigotine?

Rotigotine, a dopamine agonist drug delivered slowly across the skin by means of a transdermal patch, worn for 24hrs at a time. The aim is to provide a slow, steady stream of dopamine in order to reduce symptoms and on/off fluctuations.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 152 22 Efficacy_major Efficacy_moderate Efficacy_cant_tell
Stiffness/Spasticity 8 1 Efficacy_moderate
Tremor 2 0
General health 2 0
Improve mobility 2 1 Efficacy_moderate
Increase effect of another treatment 1 0

See all 68 patients currently taking Rotigotine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 4
Mild
 8
None
 9

Commonly reported side effects, conditions, and hospitalizations associated with Rotigotine

Fatigue 3
Nausea 2
Anxious mood 2
Skin eruptions 2
Edema in lower extremities 1
Fuzzy thinking 1
See all 11 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Rotigotine. See all 23 dosages ►

  6 mg all the time (24/7) 4 mg all the time (24/7) 2 mg daily 4 mg daily 6 mg/24 hr daily 6 mg daily 8 mg/24h daily 8 mg daily 2 x 6 mg/24 hr daily 16 mg daily
  5 Number of Patients: 5 3 Number of Patients: 3 4 Number of Patients: 4 4 Number of Patients: 4 8 Number of Patients: 8 14 Number of Patients: 14 2 Number of Patients: 2 5 Number of Patients: 5 2 Number of Patients: 2 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Rotigotine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 55   Other: 49%
Did not seem to work 24   Did not seem to work: 21%
Side effects too severe 23   Side effects too severe: 20%
Doctor's advice 20   Doctor's advice: 18%
Course of treatment ended 6   Course of treatment ended: 5%
Not indicated 6   Not indicated: 5%
Expense 2   Expense: 2%
Personal research 1   Personal research: 1%
Change in health plan coverage 1   Change in health plan coverage: 1%

See all 112 patients who’ve stopped taking Rotigotine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Rotigotine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Rotigotine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Rotigotine

Always
 19 83%
Usually
 2 9%
Sometimes
 1 4%
Never
 1 4%

Burden

Difficulty being on treatment

Burden of Rotigotine

Very
 2 9%
Somewhat
 8 35%
A little
 4 17%
Not at all
 9 39%

Cost

Paid out of pocket

Cost of Rotigotine

$200+
 4 31%
$100-199
 1 8%
$50-99
 2 15%
$25-49
 0 0%
< $25
 6 46%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.